The results of this study have been published in the scientific journal Archives of Bronconeumology and it has been lead by members of the Early Cancer Detection group of the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan nstitute of Oncology (ICO).
A study estimates the number of people at high risk of developing lung cancer in Spain Read More »
Last Friday, October 22, the sixth edition of IDIBELL’s PhD Day took place in the Faculty of Medicine and Health Sciences of the University of Barcelona. In this edition, it has been presented 10 oral communications and 44 scientific posters.
The PhD Day returns this year stronger than ever Read More »
One of the hallmarks of Parkinson’s disease is the abnormal accumulation of the α-synuclein protein that causes neuronal death responsible for motor impairments. Dendrimers are highly branched polymers that decrease α-synuclein accumulation in dopaminergic neurons derived from patient stem cells.
Researchers from IDIBELL and ICO describe that CDK4 and CDK6 inhibitors stop tumor cell proliferation and expand the life expectancy in animal models.
Coinciding with the commemoration of World Breast Cancer Day, the Viladecans Against Cancer Association held the opening ceremony of its new fundraising campaign for research
The Viladecans Against Cancer Association launches the new fundraising campaign Read More »
Curiosity will be the object of study of the scientific experiment “Being a Curious Music-Mind” of IDIBELL with DJ Alicia Carrera, which will take place at the CCCB and Sala Salamandra on October 29 and 30.
IDIBELL and UB researchers, together with Mount Sinai, have described a group of microRNAs that would regulate Wnt/β-catenin signalling pathway-dependent breast cancers.
For the first time, one of the variants identified is unrelated to psychiatric disorders and would contribute through other factors such as smoking, insomnia, or the propensity to risk-taking.
Fluorizoline was known for its pro-apoptotic action on various tumor cells. Now, a study by IDIBELL and the University of Barcelona shows that apart from promoting cell death, this compound inhibits the degradation of mitochondria.
The ability to inhibit mitophagy converts fluorizoline into a promising antitumor agent Read More »
Dr. Mònica Povedano, principal investigator at IDIBELL and head of the Functional Unit for Motor Neuron Disease at the Bellvitge University Hospital, has been awarded the 2020 Neuromuscular Disease Prize (scientific modality), granted by the Spanish Society of Neurology (SEN).
Recognition of Dr. Mònica Povedano and the Functional Unit for Motor Neuron Disease work Read More »
